(2003; 211 pages)
1. Webb DG, Horne R, Pinching AJ. Treatment-related empowerment: preliminary evaluation of a new measure in patients with advanced HIV disease. International Journal of STD & AIDS, 2001, 12: 103-107.
2. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 1999, 47: 555-567.
3. Horne R. Patients' beliefs about treatment: the hidden determinant of treatment outcome? Journal of Psychosomatic Research, 1999, 47: 491-495.
4. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, World Health Organization, 2002.
5. Cramer JA. Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence. American Journal of Managed Care, 1998, 4: 1563-1568.
6. Dunbar-Jacob J et al. Adherence in chronic disease. Annual Review of Nursing Research, 2000, 18: 48-90.
7. Sarquis LM et al. [Compliance in antihypertensive therapy: analyses in scientific articles.] [Portuguese] Revista Da Escola de Enfermagem Da USP, 1998, 32: 335-353.
8. Clark DO. Issues of adherence, penetration, and measurement in physical activity effectiveness studies. Medical Care, 2001, 39: 409-412.
9. Green CA. What can patient health education coordinators learn from ten years of compliance research? Patient Education & Counseling, 1987, 10: 167-174.
10. Rayman RB. Health promotion: a perspective. Aviation Space & Environmental Medicine, 1988, 59: 379-381.
11. Scheen AJ. [Therapeutic non-compliance: a major problem in the prevention of cardiovascular diseases.] [French] Revue Médicale de Liège, 1999, 54: 914-920.
12. Macroeconomics and Health: Investing in Health for Economic Development - Report of the Commission on Macroeconomics and Health. Geneva, World Health Organization, 2001.
13. Burke LE, Dunbar-Jacob JM, Hill MN. Compliance with cardiovascular disease prevention strategies: a review of the research. Annals of Behavioral Medicine, 1997, 19: 239-263.
14. Waeber B, Burnier M, Brunner HR. How to improve adherence with prescribed treatment in hypertensive patients? Journal of Cardiovascular Pharmacology, 2000, 35 (Suppl 3): S23-S26.
15. Luscher TF et al. Compliance in hypertension: facts and concepts. Journal of Hypertension (Suppl), 1985, 3: S3-S9.
16. Psaty BM et al. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. Journal of the American Medical Association, 1990, 263: 1653-1657.
17. Rogers PG, Bullman W. Prescription medicine compliance: review of the baseline of knowledge - report of the National Council on Patient Information and Education. Journal of Pharmacoepidemiology, 1995, 3: 3-36.
18. Beckles GL et al. Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care, 1998, 21: 1432-1438.
19. Khalil SA, Elzubier AG. Drug compliance among hypertensive patients in Tabuk, Saudi Arabia. Journal of Hypertension, 1997, 15: 561-565.
20. Elzubier AG et al. Drug compliance among hypertensive patients in Kassala, eastern Sudan. Eastern Mediterranean Health Journal, 2000, 6: 100-105.
21. Swinburn BA, Metcalf PA, Ley SJ. Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care, 2001, 24: 619-624.
22. Foreyt JP, Poston WS. The challenge of diet, exercise and lifestyle modification in the management of the obese diabetic patient. International Journal of Obesity, 1999, 23 (Suppl 7): S5-S11.
23. Anderson BJ, Vangsness L, Connell A. Family conflict, adherence, and glycaemic control in youth with short duration Type 1 diabetes. Diabetic Medicine, 2002, 19: 635-642.
24. Thompson C et al. Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and a tricyclic antidepressant. American Journal of Psychiatry, 2000, 157: 338-343.
25. Stein MD et al. Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use. American Journal of Drug & Alcohol Abuse, 2000, 26: 195-205.
26. Gifford AL et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 2000, 23: 386-395.
27. Paterson DL et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 2000, 133: 21-30.
28. Tuldra A et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 2000, 25: 221-228.
29. Bangsberg DR et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 2000, 14: 357-366.
30. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clinical Infectious Disease, 2000, 30 (Suppl 2): S171-S176.
31. Murri R et al. Patient-reported nonadherence to HAART is related to protease inhibitor levels. Journal of Acquired Immune Deficiency Syndromes, 2000, 24: 123-128.
32. Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Social Science and Medicine, 2000, 50: 1599-1605.
33. Holman HR et al. Evidence that an education program for self-management of chronic disease can improve health status while reducing health care costs: a randomized trial. Abstract Book/Association for Health Services Research, 1997, 14: 19-20.
34. Gibson PG et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database of Systematic Reviews, 2001.
35. Sloss EM et al. Selecting target conditions for quality of care improvement in vulnerable older adults. Journal of the American Geriatrics Society, 2000, 48: 363-369.
36. Mar J, Rodriguez-Artalejo F. Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance? Journal of Hypertension (Suppl), 2001, 19: 149-155.
37. Massanari MJ. Asthma management: curtailing cost and improving patient outcomes. Journal of Asthma, 2000, 37: 641-651.
38. Balkrishnan R, Christensen DB. Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary disease. Clinical Therapeutics, 2000, 22: 452-469.
39. Kokubu F et al. [Hospitalization reduction by an asthma tele-medicine system.] [Japanese] Arerugi - Japanese Journal of Allergology, 2000, 49: 19-31.
40. On-demand use of 2 agonists led to better asthma control than did regular use in moderate-to-severe asthma. ACP Journal Club, 2001, 134: 17.
41. Valenti WM. Treatment adherence improves outcomes and manages costs. AIDS Reader, 2001, 11: 77-80
42. McPherson-Baker S et al. Enhancing adherence to combination antiretroviral therapy in nonadherent HIV-positive men. AIDS Care, 2000, 12: 399-404.
43. Ostrop NJ, Hallett KA, Gill MJ. Long-term patient adherence to antiretroviral therapy. Annals of Pharmacotherapy, 2000, 34: 703-709.
44. Desvarieux M et al. A novel approach to directly observed therapy for tuberculosis in an HIV-endemic area. American Journal of Public Health, 2001, 91: 138-141.
45. Put C et al. A study of the relationship among self-reported noncompliance, symptomatology, and psychological variables in patients with asthma. Journal of Asthma, 2000, 37: 503-510.
46. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Archives of Internal Medicine, 2000, 27: 3278-3285.
47. Rohland BM, Rohrer JE, Richards CC. The long-term effect of outpatient commitment on service use. Administration & Policy in Mental Health, 2000, 27: 383-394.
48. Bangsberg DR et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 2000, 14: 357-366.
49. Gallego O et al. Drug resistance in patients experiencing early virological failure under a triple combination including indinavir. AIDS, 2001, 15: 1701-1706.
50. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clinics in Infectious Disease, 2000, 30: S171-S176.
51. Wahl LM, Nowak MA. Adherence and drug resistance: predictions for therapy outcome. Proceedings of the Royal Society of London - Series B: Biological Sciences, 2000, 267: 835-843.
52. Markowitz M. Resistance, fitness, adherence, and potency: mapping the paths to virologic failure. Journal of the American Medical Association, 2000, 283: 250-251.
53. Haynes RB. Interventions for helping patients to follow prescriptions for medications. Cochrane Database of Systematic Reviews, 2001.
54. Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Social Science & Medicine, 2000, 50: 1599-1605.
55. Johnson KH, Bazargan M, Bings EG. Alcohol consumption and compliance among inner-city minority patients with type 2 diabetes mellitus. Archives of Family Medicine, 2000, 9: 964-970.
56. Weiden P. Adherence to antipsychotic medication: key facts. Schizophrenia Home Page, 2002 (www.schizophrenia.com/ami/coping/noncompli2.htm).
57. Bush PJ, Spector KK, Rabin DL. Use of sedatives and hypnotics prescribed in a family practice. Southern Medical Journal, 1984, 77: 677-681.
58. Demyttenaere K, Haddad P. Compliance with antidepressant therapy and antidepressant discontinuation symptoms. Acta Psychiatrica Scandinavica, 2000, 403: 50-56.
59. Kaplan EM. Antidepressant noncompliance as a factor in the discontinuation syndrome. Journal of Clinical Psychiatry, 1997, 58: 31-35.
60. Wahl LM, Nowak MA. Adherence and drug resistance: predictions for therapy outcome. Proceedings of the Royal Society of London - Series B: Biological Sciences, 2000, 267: 835-843.
61. Paterson DL et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 2000, 133: 21-30.
62. Yach D. Tuberculosis in the Western Cape health region of South Africa. Social Science & Medicine, 1988, 27: 683-689.
63. Bell J, Yach D. Tuberculosis patient compliance in the western Cape, 1984. South African Medical Journal, 1988, 73: 31-33.
64. Ehiri BI. Improving compliance among hypertensive patients: a reflection on the role of patient education. International Journal of Health Promotion & Education, 2000, 38: 104-108.
65. Haynes RB et al. Interventions for helping patients follow prescriptions for medications. Cochrane Database of Systematic Reviews, 2001.
66. Ammerman AS et al. Physician-based diet counseling for cholesterol reduction: current practices, determinants, and strategies for improvement. Preventive Medicine, 1993, 22: 96-109.
67. DiMatteo MR, DiNicola DD. Achieving patient compliance. New York, Pergamon, 1982.
68. Meichenbaum D, Turk DC. Facilitating treatment adherence: A practitioner's guidebook. New York, Plenum Press, 1987.
69. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet, 1996, 348: 383-386 [erratum published in Lancet, 1997, 3499059: 1180].